Large panels in clinical routine? A reality check from a molecular pathologist
Play • 13 min

After talking about large panel testing in molecular oncology in the first episode of your ONCOmmunity podcast, let’s take a look behind the scenes of a molecular pathology laboratory.

Professor Michael Hummel is head of the molecular pathology department at the Charité Hospital in Berlin. His pathology laboratory performs comprehensive molecular genomic testing on cancer patients in everyday clinical practice. In this episode, Prof. Hummel will share the experience acquired in using NGS in pathology over the last six years and his insights on the future developments in the field of molecular genomic tumour analysis.

In the area of approved biomarkers and therapies, it is very clearly defined what we have to depict in our reports. It becomes more difficult with broad genomic testing that goes beyond the approved target structures. The availability of according therapeutic agents that match the respective molecular changes of the patient is often a major challenge”, he mentions about the clinical utility of large panels.

ONCOmmunity

More episodes
Search
Clear search
Close search
Google apps
Main menu